Invivoscribe - Improving Lives with Precision Diagnostics®
Invivoscribe offers a full range of oncology testing products and services (B- and T-cell clonality, NGS gene panels, MRD assays, and comprehensive bioinformatics software), all developed under ISO 13485 design control and manufactured in our cGMP facility. We are following this study testing with our internationally standardized NPM1 MRD Assay, confident that this productive partnership will bring further advancements and benefits to AML patients worldwide. Looking ahead, we are focused on further expanding and aligning our services globally. We are actively transferring and validating our service offerings of NGS tests, gene panels, bioinformatics, multiparametric flow cytometry assays, and MRD applications through our network of fully accredited laboratories in San Diego, Japan, China, and Germany to support clinical and pharma partners worldwide. Our goal is to assist our clinical trial partners seeking to expand enrollment in their international clinical trials, while maintaining patient confidentiality. Invivoscribe provides a proven strategy to accelerate drug approvals, offering Product Development, Manufacturing, Clinical Lab Services and Global Regulatory Expertise. Invivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls. Invivoscribe Marketing2024-03-03T11:41:21-08:00March 1st, 2024|2024 Publications, Featured Publications, Publications|.
This company is:
Verified
Controls - Plasmid DNA, DNA, RNA Extracted From Cell Lines
Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.
Verified
ABI Fluorescence Detection (CE-IVD) - IdentiClone, FLT3, ITD, and TKD
PCR-based assays for ABI fluorescence detection, including targeted FLT3 ITD, TKD mutation, B- and T-cell clonality, and translocation assays
Verified
Next-Generation Sequencing (CE-IVD) - Powerful DNA Sequencing Assays
Developed for use with Illumina MiSeq & Thermo Fisher Ion S5/PGM. NGS allows for massively parallel sequencing of millions of DNA fragments.
View all products
Keywords
Industries
How many employees does Invivoscribe Technologies approximately have?
As of the latest available information Invivoscribe Technologies has around 51-100 employees worldwide.
When was Invivoscribe Technologies founded?
Invivoscribe Technologies was founded in 1995
In which industries does Invivoscribe Technologies mainly work?
The company Invivoscribe Technologies has it's main focus in the industries of Health Care, Science and Engineering, Biotechnology
What is the current company status of Invivoscribe Technologies?
Based on the founding year and the amount of employees the company Invivoscribe Technologies seems to be a Medium-Sized Company at the current state. Note that over time that status can change
Inivata
United States
51-100 Employees
2014
Future Diagnostics Solutions
Netherlands
51-100 Employees
1997
InVivo Biotech Services GmbH
51-100 Employees
1998
Nextgen Laboratories, Inc.
United States
11-50 Employees
2015
NOVIGENIX
Switzerland
11-50 Employees
2014
National Genetics Institute
United States
251-500 Employees
1991
Avance Biosciences Inc.
United States
11-50 Employees
2011
Sysmex Inostics
Germany
51-100 Employees
2008
Topics which have been searched by others and may be interesting for you: